Nanexa AB
NANEXA | FN
Overview
Corporate Details
- ISIN(s):
- SE0007074166 (+2 more)
- LEI:
- 549300J5L2ECZTLID491
- Country:
- Sweden
- Address:
- Virdings Allé 2, 754 50 Uppsala
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Nanexa AB develops drug delivery systems based on nanotechnology. Their technology enhances the efficacy and safety of pharmaceuticals.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cyclezyme AB | Sweden | CYCLE | |
|
Cyxone AB | Sweden | CYXO | |
|
DBV Technologies | France | DBV | |
|
DEINOVE | France | ALDEI | |
|
Deutsche Biotech Innovativ AG | Germany | DBI | |
|
Devyser Diagnostics | Sweden | DVYSR | |
/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749976242&Signature=U7SlXpUXTrqkFob5nEWy16WPfNGoUKCsXykC94TJEiIcXn48JN41lymYpz-Upq6BxOjTc0fW3YRUttvtCJL~TPRJzi-CMF7Me-t797c8mfqvUabGoYIXLdLFcT~IO58jx6q04MLskjf~xoDfsa6ffQEg6WKGYX7ZZtGYdJFVW7VKQjCQxj5kA8~jbI14PMKIEGBy4VwYyYb-674PRvRiIUO8b~bXahqWKiPWarxYcsqnOaLclCZGJZ6SB2fMpeAwG1bZHW0mnB8Ff2-cKfmQQL6ix4S5DpPbVE0i718dVh6Jm2F8Ult-xzlTnAkoQDsZkNWS717Ei2SUbyNHRBoDKQ__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Diamyd Medical AB (publ) | Sweden | DMYD | |
|
Diasorin | Italy | DIA | |
| DNA Group (T.R.) Ltd. | Israel | DNA | ||
|
Double Bond Pharmaceutical International AB | Sweden | DBP B |